FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to field of medicine and pharmaceutics and represents visualisation agent, suitable for optical visualisation of mammalian organism in vivo, which includes conjugate of pentamethinecyanine colorant with biological molecule-target (RGD-peptide).
EFFECT: invention ensures creation of conjugates of pentamethinecyanine colorants, suitable for study in vivo, characterised by reduced non-specified binding in vivo, for instance, with plasma proteins.
26 cl, 11 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| OPTICAL VISUALISATION AGENTS | 2008 |
|
RU2484111C9 |
| PEPTIDE COMPOUNDS | 2005 |
|
RU2393167C2 |
| MARKED PEPTIDES BINDING HEPATOCYTE GROWTH FACTOR (HGF) FOR VISUALISATION | 2008 |
|
RU2473361C9 |
| COMPOSITION FOR OPTICAL VISUALIZATION, METHOD OF ITS PRODUCTION AND USE | 2019 |
|
RU2802481C2 |
| VISUALISATION TECHNIQUE | 2008 |
|
RU2505316C2 |
| CONTRAST AGENT AIMED AT UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR | 2005 |
|
RU2394837C2 |
| COVALENTLY LINKED CONJUGATES CHELICAR-ANTIBODY AGAINST CHELICAR AND USE THEREOF | 2014 |
|
RU2694981C2 |
| DIAGNOSTIC COMPOUNDS | 2005 |
|
RU2396272C9 |
| PEPTIDE COMPOSITION OF RADIOACTIVE INDICATORS | 2011 |
|
RU2594167C2 |
| CONJUGATE OF A FLUORESCENT DYE WITH A PEPTIDE SUBSTANCE WHICH CONTAINS A PSMA-BINDING LIGAND BASED ON A UREA DERIVATIVE FOR VISUALIZING CELLS EXPRESSING PSMA, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2019 |
|
RU2713151C1 |
